Position in GH
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$28,955
+$11,128 QoQ
Shares Held
193
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#489
of 593 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ROTHSCHILD INVESTMENT LLC holds $27,460,652 across 31 Diagnostics & Research names. GH ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
30,021 | $15,051,328 | |
| 2 | DHR |
Danaher Corp /De/
|
17,252 | $3,286,160 | |
| 3 | ICLR |
Icon PLC
|
9,811 | $1,704,268 | |
| 4 | A |
Agilent Technologies, Inc.
|
12,482 | $1,657,984 | |
| 5 | NTRA |
Natera, Inc.
|
5,722 | $1,553,236 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
2,852 | $1,510,390 | |
| 7 | ILMN |
Illumina, Inc.
|
5,910 | $1,039,155 | |
| 8 | SHC |
Sotera Health Co
|
32,287 | $573,094 |
All Filings in GH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,955 | 193 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $17,827 | 193 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $19,508 | 191 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $11,246 | 180 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $12,749 | 245 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $9,372 | 220 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $4,429 | 145 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,523 | 110 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,588 | 55 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $206 | 10 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||